NIH Testifies About FY 2011 Research Budget
The National Institutes of Health (NIH) testified before the House Appropriations Subcommittee on Labor, Health and Human Services, and Education (LHHS) about the "crunch" NIH will face in fiscal year (FY) 2011 when a two-year allotment of $10.4 billion in stimulus funding for research runs out. The LHHS Subcommittee determines the annual funding level for the NIH.
In the hearing, House appropriators spent two hours exploring topics as varied as pancreatic cancer, children's health and the success rate in completing cancer trials. But the ever-present scramble for money was a continuing theme. According to NIH Director Francis Collins, NIH grant applicants had a 25 to 30 percent chance of success at obtaining funding, but more recently that has dropped to 20 percent during the last 30 years. In FY 2011, Collins predicted that just 15 percent of grants would be funded as the spigot of money provided through the economic stimulus law shuts off.
This fiscal year, NIH has a $31 billion budget, not including about $5 billion allocated through the stimulus package. The President included an increase of $1 billion in FY 2011 for a total of $32 billion for NIH. That is an increase of about 3.2 percent which matches the inflationary index for biomedical research. The IMF advocates $35.2 billion in FY 2011 for the NIH.
Do Your Congressional Members Support IMF Issues?
Have your Congressional Members cosponsored legislation that is important to myeloma patients? If not, please visit the Advocacy Action Center at www.advocacy.myeloma.org to send an e-mail today.